Neurology
News
NIH panel identifies ME/CFS research gaps, priorities
News
FDA: No changes needed in management of ezogabine’s eye and skin effects
Pigment changes in the retina reported in some patients treated with the antiseizure drug ezogabine do not appear to affect vision, and can be “...
Conference Coverage
ICOO: Opioids blurring criminal activity and malpractice
Commentary
Steroids for sciatica
Conference Coverage
ICOO: Nonspecialist comfort with opioids remains low
Key clinical point: Pain specialists have a long way to go to improve the comfort of primary care specialists with managing patients on opioids,...
Conference Coverage
Cognitive impairment signals subclinical vascular disease
Key clinical point: Assessing cognitive function could help identify subclinical vascular disease. Major finding: Stroke (RR, 1.57; P = .010) and...
Conference Coverage
Pharmacogenomics for pain meds promising but not ready
Genetic tests for pain treatment efficacy are being marketed in the United States and Australia, but one expert argues that they are not ready for...
Conference Coverage
Reperfusion best predicts post-stroke outcomes
Key clinical point: Early reperfusion may be a better marker of poststroke outcomes than recanalization. Major finding: Reperfusion was associated...
Conference Coverage
Handheld ECG helps spot atrial fibrillation after stroke
Key clinical point: Handheld ECG monitoring may be a practical way to monitor AF risk following a stroke/TIA.
News
ACIP recommends MenB vaccination for at-risk groups
Conference Coverage
ICOO: Massachusetts governor takes on opioid epidemic
The governor of Massachusetts, Charles D. Baker, promises to create viable strategies aimed at addressing the prescription opioid epidemic.